Cargando…

Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up

To compare the Stretta procedure with proton pump inhibitors for the treatment of nonerosive reflux disease (NERD). From July 2018 to April 2019, patients diagnosed with NERD and referred for treatment were enrolled. They were treated with either Stretta procedure or proton pump inhibitor (PPI) medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Suyu, Xu, Fei, Xiong, Xin, Wang, Hui, Cao, Lipeng, Liang, Ninglin, Wang, Hanmei, Jing, Xiaojuan, Liu, Tianyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220108/ https://www.ncbi.nlm.nih.gov/pubmed/32011441 http://dx.doi.org/10.1097/MD.0000000000018610

Ejemplares similares

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
por: Zheng, Ya-Mei, et al.
Publicado: (2021)

Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors
por: Jiang, Liuqin, et al.
Publicado: (2016)

The prevalence of coronary atherosclerosis in patients with refractory gastroesophageal reflux disease ready for antireflux surgery
por: Zhang, Xiumei, et al.
Publicado: (2022)

Nonerosive Reflux Disease (NERD) - An Update
por: Hershcovici, Tiberiu, et al.
Publicado: (2010)

Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides
por: Di Pierro, Francesco, et al.
Publicado: (2013)

Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014)

In Which Situation is Endoscopic Radiofrequency Anti-Reflux Therapy (Stretta) Effective for Controlling Gastroesophageal Reflux Symptoms?
por: Jung, Hwoon-Yong
Publicado: (2021)

Current Advances in the Diagnosis and Treatment of Nonerosive Reflux Disease
por: Chen, Chien-Lin, et al.
Publicado: (2013)

Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease
por: Xu, Cao, et al.
Publicado: (2022)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Stretta radiofrequency treatment vs Toupet fundoplication for gastroesophageal reflux disease: a comparative study
por: Ma, Lifeng, et al.
Publicado: (2020)

On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
por: Khan, Zubair, et al.
Publicado: (2018)

Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients
por: Fernandes, Michel R, et al.
Publicado: (2018)

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease
por: Ye, Bi Xing, et al.
Publicado: (2017)

Peroral endoscopic cardial constriction in gastroesophageal reflux disease
por: Hu, Hai-Qing, et al.
Publicado: (2018)

Celiac disease serology and gut microbiome following proton pump inhibitor treatment
por: Jang, Sophie, et al.
Publicado: (2020)

Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
por: Odaka, Takeo, et al.
Publicado: (2017)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Role of Saliva in Esophageal Defense: Implications in Patients With Nonerosive Reflux Disease
por: Yandrapu, Harathi, et al.
Publicado: (2015)

Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease
por: Park, Joong-Min, et al.
Publicado: (2018)

Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis
por: Guo, Zihao, et al.
Publicado: (2021)

Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis
por: Cheng, Tao, et al.
Publicado: (2021)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Correlation of Narrow Band Imaging Endoscopy and Histopathology in the Diagnosis of Nonerosive Reflux Disease
por: Arul, P, et al.
Publicado: (2015)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Laparoscopic revision surgery for gastroesophageal reflux disease
por: Celasin, Haydar, et al.
Publicado: (2017)

The Outcome of Endoscopic Radiofrequency Anti-Reflux Therapy (STRETTA) for Gastroesophageal Reflux Disease in Patients with Previous Gastric Surgery: A Prospective Cohort Study
por: Nevins, Edward John, et al.
Publicado: (2021)

Severe reflux esophagitis and multiple congenital defects: A case report
por: Ma, Jia-Yi, et al.
Publicado: (2020)

Durability of Stretta Radiofrequency Treatment for GERD: Results of an 8-Year Follow-Up
por: Dughera, Luca, et al.
Publicado: (2014)

Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis
por: Li, Mei-Juan, et al.
Publicado: (2017)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Whether long-term use of proton pump inhibitor increases the risk of precancerous lesions in the stomach: A systematic review and meta-analysis of randomized controlled trials
por: Lv, Fangyi, et al.
Publicado: (2023)

Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms
por: Kim, Jin Joo, et al.
Publicado: (2016)

Reflux esophagitis in patients with chronic obstructive pulmonary disease
por: Kang, Hyeon Hui, et al.
Publicado: (2021)

Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis
por: Yang, Sensen, et al.
Publicado: (2022)

Association between gastroesophageal reflux disease and vocal fold polyps
por: Zou, Yazhu, et al.
Publicado: (2021)

Characteristics of Symptom Presentation and Risk Factors in Patients with Erosive Esophagitis and Nonerosive Reflux Disease
por: Lee, Shou-Wu, et al.
Publicado: (2014)

Multichannel impedance monitoring for distinguishing nonerosive reflux esophagitis with minor changes on endoscopy in children
por: Junko, Fujino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv7n49dfab669lapho1t213cnf